Strategies for drug discovery by targeting sulfation pathways.
Posttranslational modifications of proteins such as phosphorylation have been recognized as pivotal modulators of biological activity in healthy and diseased tissues. Sulfation is a key posttranslational modification the role of which in physiology and pathology is only now becoming appreciated. Whereas phosphorylation is central to intracellular signal transduction, sulfation modulates cell-cell and cell-matrix communication. Sulfation involves a class of enzymes known as sulfotransferases, which transfer sulfate from the ATP-like sulfate donor 3'phosphoadenosine-5'phosphosulate to glycoproteins, glycolipids or metabolites. This review focuses on Golgi-localized sulfotransferases, their molecular biology and biochemistry, and strategies towards discovery of sulfotransferase inhibitors that could have potential as therapeutics in inflammation, cancer and infectious diseases.
Hemmerich
Stefan
S
Thios Pharmaceuticals, 5980 Horton Street #400, Emeryville, CA 94608, USA. stefan@thiospharm.com
Verdugo
Dawn
D
Rath
Virginia L
VL
D000818:Animals; D015195:Drug Design; D006056:Golgi Apparatus / Q000378:metabolism; D006801:Humans; D011499:Protein Processing, Post-Translational; D020543:Proteome; D015238:Sulfotransferases / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism*
D020543:Proteome; D015238:Sulfotransferases